Patrick J. Heron - 04 Mar 2024 Form 4 Insider Report for Arcutis Biotherapeutics, Inc. (ARQT)

Role
Director
Signature
/s/ Steve R. Bailey, Attorney-in-Fact For Patrick J. Heron
Issuer symbol
ARQT
Transactions as of
04 Mar 2024
Net transactions value
+$199,994
Form type
4
Filing time
06 Mar 2024, 16:28:21 UTC
Previous filing
14 Nov 2023
Next filing
07 Jun 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ARQT Common Stock Purchase $199,994 +21,052 +0.24% $9.50 8,785,284 04 Mar 2024 By Frazier Life Sciences VIII, L.P. F1
holding ARQT Common Stock 7 04 Mar 2024 By FHM Life Sciences VIII, L.L.C. F2
holding ARQT Common Stock 23,688 04 Mar 2024 By The Heron Living Trust 11/30/2004 F3
holding ARQT Common Stock 8,687 04 Mar 2024 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares are held directly by Frazier Life Sciences VIII, L.P. FHM Life Sciences VIII, L.P. is the general partner of Frazier Life Sciences VIII, L.P. and FHM Life Sciences VIII, L.L.C. is the general partner of FHM Life Sciences VIII, L.P. James N. Topper and the Reporting Person are the sole managing members of FHM Life Sciences VIII, L.L.C. and share voting and investment power over the shares held by Frazier Life Sciences VIII, L.P. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.
F2 The shares are held directly by FHM Life Sciences VIII, L.L.C. James N. Topper and the Reporting Person are the sole managing members of FHM Life Sciences VIII, L.L.C. and share voting and investment power over the shares held by Frazier Life Sciences VIII, L.P. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.
F3 The shares are held directly by The Heron Living Trust 11/30/2004. The Reporting Person is the co-trustee of The Heron Living Trust 11/30/2004 and has voting and investment power of the securities held by The Heron Living Trust 11/30/2004.
F4 Includes 4,375 Restricted Stock Units ("RSUs"). The Reporting Person is entitled to receive one (1) share of the Issuer's Common Stock for each one (1) RSU upon the vesting thereof.